Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C13H20N2O3S |
| Molecular Weight | 284.374 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)\C=C1/S[C@H](N2CCCCC2)C(=O)N1C
InChI
InChIKey=ZCKKHYXUQFTBIK-XPSMFNQNSA-N
InChI=1S/C13H20N2O3S/c1-3-18-11(16)9-10-14(2)12(17)13(19-10)15-7-5-4-6-8-15/h9,13H,3-8H2,1-2H3/b10-9-/t13-/m0/s1
| Molecular Formula | C13H20N2O3S |
| Molecular Weight | 284.374 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
Dexetozoline is a safe and effective diuretic agent in the treatment of acute cardiac failure. In isolated rings of guinea-pig aorta not responding to acetylcholine, the diuretic dexetozoline did not influence basal vascular tone but inhibited noradrenaline- and histamine-induced contractions. Dexetozoline has a very high bioavailability after oral administration and is fairly lipohilic. The half-life of etozolin is 2.5 h. Dexetozoline accumulates in cirrhosis.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:33:23 GMT 2023
by
admin
on
Fri Dec 15 16:33:23 GMT 2023
|
| Record UNII |
KK9WYJ6556
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C270
Created by
admin on Fri Dec 15 16:33:23 GMT 2023 , Edited by admin on Fri Dec 15 16:33:23 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
77519-25-6
Created by
admin on Fri Dec 15 16:33:23 GMT 2023 , Edited by admin on Fri Dec 15 16:33:23 GMT 2023
|
PRIMARY | |||
|
DTXSID601024609
Created by
admin on Fri Dec 15 16:33:23 GMT 2023 , Edited by admin on Fri Dec 15 16:33:23 GMT 2023
|
PRIMARY | |||
|
5093
Created by
admin on Fri Dec 15 16:33:23 GMT 2023 , Edited by admin on Fri Dec 15 16:33:23 GMT 2023
|
PRIMARY | |||
|
SUB07027MIG
Created by
admin on Fri Dec 15 16:33:23 GMT 2023 , Edited by admin on Fri Dec 15 16:33:23 GMT 2023
|
PRIMARY | |||
|
KK9WYJ6556
Created by
admin on Fri Dec 15 16:33:23 GMT 2023 , Edited by admin on Fri Dec 15 16:33:23 GMT 2023
|
PRIMARY | |||
|
637492
Created by
admin on Fri Dec 15 16:33:23 GMT 2023 , Edited by admin on Fri Dec 15 16:33:23 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106290
Created by
admin on Fri Dec 15 16:33:23 GMT 2023 , Edited by admin on Fri Dec 15 16:33:23 GMT 2023
|
PRIMARY | |||
|
76333-71-6
Created by
admin on Fri Dec 15 16:33:23 GMT 2023 , Edited by admin on Fri Dec 15 16:33:23 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
100000083222
Created by
admin on Fri Dec 15 16:33:23 GMT 2023 , Edited by admin on Fri Dec 15 16:33:23 GMT 2023
|
PRIMARY | |||
|
C78047
Created by
admin on Fri Dec 15 16:33:23 GMT 2023 , Edited by admin on Fri Dec 15 16:33:23 GMT 2023
|
PRIMARY | |||
|
278-423-7
Created by
admin on Fri Dec 15 16:33:23 GMT 2023 , Edited by admin on Fri Dec 15 16:33:23 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
RACEMATE -> ENANTIOMER |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
